Westpac Banking Corp cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 7.6% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 27,152 shares of the company’s stock after selling 2,232 shares during the period. Westpac Banking Corp’s holdings in Cardinal Health were worth $6,041,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in CAH. Downshift Financial LLC boosted its stake in shares of Cardinal Health by 3,666.7% in the third quarter. Downshift Financial LLC now owns 113 shares of the company’s stock valued at $25,000 after purchasing an additional 110 shares during the period. Maryland Capital Advisors Inc. grew its holdings in Cardinal Health by 12,600.0% during the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock valued at $28,000 after purchasing an additional 126 shares in the last quarter. Investors Research Corp purchased a new stake in Cardinal Health during the 2nd quarter worth $29,000. Allied Private Wealth LLC purchased a new stake in Cardinal Health during the 2nd quarter worth $30,000. Finally, Brown Lisle Cummings Inc. lifted its holdings in Cardinal Health by 1,562.5% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 133 shares of the company’s stock worth $30,000 after buying an additional 125 shares in the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.
Cardinal Health Trading Down 2.1%
Shares of NYSE:CAH opened at $272.49 on Friday. The company has a fifty day simple moving average of $247.18 and a 200 day simple moving average of $226.54. The firm has a market cap of $62.98 billion, a PE ratio of 35.25, a price-to-earnings-growth ratio of 2.13 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.94 by $0.32. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm had revenue of $67.51 billion for the quarter, compared to analysts’ expectations of $66.67 billion. During the same period in the prior year, the company posted $2.55 earnings per share. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 12.96 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, January 4th. Cardinal Health’s dividend payout ratio is 26.65%.
Analyst Ratings Changes
A number of equities analysts have weighed in on CAH shares. Argus upped their price objective on shares of Cardinal Health from $264.00 to $309.00 and gave the company a “buy” rating in a research report on Thursday, November 12th. Wells Fargo & Company raised their target price on Cardinal Health from $277.00 to $321.00 and gave the company an “overweight” rating in a research note on Tuesday. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $260.00 to $286.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 10th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, October 25th. Finally, Royal Bank Of Canada increased their price target on Cardinal Health from $276.00 to $295.00 and gave the company an “outperform” rating in a report on Friday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $290.13.
Read Our Latest Research Report on CAH
About Cardinal Health
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
See Also
- Five stocks we like better than Cardinal Health
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
